Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002, 2 (1): 48-58. 10.1038/nrc706.
Article
CAS
PubMed
Google Scholar
Lacayo NJ, Duran GE, Sikic BI: Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells. J Exp Ther Oncol. 2003, 3 (3): 127-135. 10.1046/j.1359-4117.2003.01088.x.
Article
CAS
PubMed
Google Scholar
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM: Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999, 39: 361-398. 10.1146/annurev.pharmtox.39.1.361.
Article
CAS
PubMed
Google Scholar
Meyer S, Kohler NG, Joly A: Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappa B activation. FEBS Lett. 1997, 413 (2): 354-358. 10.1016/S0014-5793(97)00930-7.
Article
CAS
PubMed
Google Scholar
Harding CV, France J, Song R, Farah JM, Chatterjee S, Iqbal M, Siman R: Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J Immunol. 1995, 155 (4): 1767-1775.
CAS
PubMed
Google Scholar
Marienfeld R, Neumann M, Chuvpilo S, Escher C, Kneitz B, Avots A, Schimpl A, Serfling E: Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur J Immunol. 1997, 27 (7): 1601-1609.
Article
CAS
PubMed
Google Scholar
Piccinini M, Tazartes O, Mezzatesta C, Ricotti E, Bedino S, Grosso F, Dianzani U, Tovo PA, Mostert M, Musso A, Rinaudo MT: Proteasomes are a target of the anti-tumor drug vinblastine. Biochem J. 2001, 356 (Pt 3): 835-841. 10.1042/0264-6021:3560835.
Article
CAS
PubMed
PubMed Central
Google Scholar
Drewe J, Gutmann H, Fricker G, Torok M, Beglinger C, Huwyler J: HIV protease inhibitor ritonavir: a more potent inhibitor of P- glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol. 1999, 57 (10): 1147-1152. 10.1016/S0006-2952(99)00026-X.
Article
CAS
PubMed
Google Scholar
Schmidtke G, Holzhutter HG, Bogyo M, Kairies N, Groll M, de Giuli R, Emch S, Groettrup M: How an inhibitor of the HIV-I protease modulates proteasome activity. J Biol Chem. 1999, 274 (50): 35734-35740. 10.1074/jbc.274.50.35734.
Article
CAS
PubMed
Google Scholar
Stein RL, Melandri F, Dick L: Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry. 1996, 35 (13): 3899-3908. 10.1021/bi952262x.
Article
CAS
PubMed
Google Scholar
Gieseler F, Nussler V, Brieden T, Kunze J, Valsamas S: Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death. Int J Clin Pharmacol Ther. 1998, 36 (1): 25-28.
CAS
PubMed
Google Scholar
Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG: Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol. 2000, 18 (5): 538-543. 10.1038/75406.
Article
CAS
PubMed
Google Scholar
Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S: Apoptosis induction resulting from proteasome inhibition. Biochem J. 1996, 317 (Pt 2): 385-388.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kiyomiya K, Satoh J, Horie H, Kurebe M, Nakagawa H, Matsuo S: Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome. Int J Oncol. 2002, 21 (5): 1081-1085.
CAS
PubMed
Google Scholar
Kiyomiya K, Matsuo S, Kurebe M: Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex. Cancer Res. 2001, 61 (6): 2467-2471.
CAS
PubMed
Google Scholar
Kiyomiya K, Matsuo S, Kurebe M: Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus. Life Sci. 1998, 62 (20): 1853-1860. 10.1016/S0024-3205(98)00151-9.
Article
CAS
PubMed
Google Scholar
Sukhai M, Piquette-Miller M: Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci. 2000, 3 (2): 268-280.
CAS
PubMed
Google Scholar
Stohwasser R, Kloetzel PM: Cytokine induced changes in proteasome subunit composition are concentration dependent. Biol Chem. 1996, 377 (9): 571-577.
CAS
PubMed
Google Scholar
Yang Y, Waters JB, Fruh K, Peterson PA: Proteasomes are regulated by interferon gamma: implications for antigen processing. Proc Natl Acad Sci U S A. 1992, 89 (11): 4928-4932.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pajonk F, McBride WH: Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother Oncol. 2001, 59 (2): 203-212. 10.1016/S0167-8140(01)00311-5.
Article
CAS
PubMed
Google Scholar
Grune T: Oxidative stress, aging and the proteasomal system. Biogerontology. 2000, 1 (1): 31-40. 10.1023/A:1010037908060.
Article
CAS
PubMed
Google Scholar
Teicher BA, Ara G, Herbst R, Palombella VJ, Adams J: The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res. 1999, 5 (9): 2638-2645.
CAS
PubMed
Google Scholar
Adams J, Palombella VJ, Elliott PJ: Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs. 2000, 18 (2): 109-121. 10.1023/A:1006321828515.
Article
CAS
PubMed
Google Scholar
Zhang Z, Wu JY, Hait WN, Yang JM: Regulation of the stability of P-glycoprotein by ubiquitination. Mol Pharmacol. 2004, 66 (3): 395-403. 10.1124/mol.104.001966.
Article
CAS
PubMed
Google Scholar
Ogiso Y, Tomida A, Lei S, Omura S, Tsuruo T: Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs. Cancer Res. 2000, 60 (9): 2429-2434.
CAS
PubMed
Google Scholar
Yoshimura A, Kuwazuru Y, Sumizawa T, Ikeda S, Ichikawa M, Usagawa T, Akiyama S: Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. Biochim Biophys Acta. 1989, 992 (3): 307-314.
Article
CAS
PubMed
Google Scholar
Ghauharali RI, Westerhoff HV, Dekker H, Lankelma J: Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells. Biochim Biophys Acta. 1996, 1278 (2): 213-222.
Article
PubMed
Google Scholar
Amsterdam A, Pitzer F, Baumeister W: Changes in intracellular localization of proteasomes in immortalized ovarian granulosa cells during mitosis associated with a role in cell cycle control. Proc Natl Acad Sci U S A. 1993, 90 (1): 99-103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S, Ichihara A: Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci U S A. 1990, 87 (18): 7071-7075.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, Okada F, Sato S, Shimbara N, Ichihara A: Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res. 1991, 51 (24): 6677-6685.
CAS
PubMed
Google Scholar
Qiu JH, Asai A, Chi S, Saito N, Hamada H, Kirino T: Proteasome inhibitors induce cytochrome c-caspase-3-like protease- mediated apoptosis in cultured cortical neurons. J Neurosci. 2000, 20 (1): 259-265.
CAS
PubMed
Google Scholar
Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF: Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J Neurosci Res. 2000, 59 (5): 601-611. 10.1002/(SICI)1097-4547(20000301)59:5<601::AID-JNR3>3.0.CO;2-1.
Article
CAS
PubMed
Google Scholar
Zhang XM, Lin H, Chen C, Chen BD: Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Biochem J. 1999, 340 (Pt 1): 127-133. 10.1042/0264-6021:3400127.
Article
CAS
PubMed
PubMed Central
Google Scholar
Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, Magdelenat H: The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis [see comments]. Br J Cancer. 1998, 77 (7): 1103-1107.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bold RJ, Virudachalam S, McConkey DJ: Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. J Surg Res. 2001, 100 (1): 11-17. 10.1006/jsre.2001.6194.
Article
CAS
PubMed
Google Scholar
Pajonk F, Pajonk K, McBride W: Apoptosis and radiosensitization of Hodgkin’s cells by proteasome inhibition. Int J Radiat Oncol Biol Phys. 2000, 47 (4): 1025-1032. 10.1016/S0360-3016(00)00516-2.
Article
CAS
PubMed
Google Scholar
Russo SM, Tepper JE, Baldwin ASJ, Liu R, Adams J, Elliott P, Cusack JCJ: Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys. 2001, 50 (1): 183-193. 10.1016/S0360-3016(01)01446-8.
Article
CAS
PubMed
Google Scholar
Iwahana M, Utoguchi N, Mayumi T, Goryo M, Okada K: Drug resistance and P-glycoprotein expression in endothelial cells of newly formed capillaries induced by tumors. Anticancer Res. 1998, 18 (4C): 2977-2980.
CAS
PubMed
Google Scholar
Toth K, Vaughan MM, Peress NS, Slocum HK, Rustum YM: MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol. 1996, 149 (3): 853-858.
CAS
PubMed
PubMed Central
Google Scholar